Summary
Can-Fite BioPharma Ltd (Can-Fite) is a biopharmaceutical company that concentrates on the discovery and clinical development of drugs. The company's pipeline product portfolio comprise CF101, CF102 and CF602. Can-Fite develops drugs by utilizing its platform technology. It concentrates on developing of drugs that are used in the treatment of diseases such as cancer, sexual dysfunction, inflammatory diseases and ophthalmic indications. Can-Fite’s CF 102, is an oral drug used to treat liver cancer and CF 602, is an allosteric modulator used in the treatment of inflammatory diseases. The company performs Phase I, II and III clinical trials for various indications across the US, Europe and Israel. Can-Fite is headquartered in Petah Tikva, Israel.
Can-Fite BioPharma Ltd (CANF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Can-Fite BioPharma Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Can-Fite BioPharma Enters into Distribution Agreement with Chong Kun Dang Pharma 11
Can-Fite BioPharma To Enter Into Co-Development Agreement With Smart Assays BioTech 11
Licensing Agreements 12
Cipher Pharma Enters into Licensing Agreement with Can-Fite BioPharma for CF101 12
Equity Offering 13
Can-Fite BioPharma to Raise USD5 Million in Private Placement of ADSs 13
Can-Fite BioPharma to Raise USD4.8 Million in Private Placement of Shares 14
Can-Fite BioPharma Raises USD9 Million in Private Placement of American Depository Shares 15
Can-Fite BioPharma Raises USD8 Million in Private Placement of American Depositary Shares 16
Can-Fite BioPharma Completes Private Placement Of American Depositary Shares For US$5 Million 18
Can-Fite BioPharma Completes Public Offering Of Units For US$6 Million 19
OphthaliX Files Registration Statement For Public Offering Of Shares For US$10 Million 20
Can-Fite BioPharma Completes Public Offering Of Units For US$7.2 Million 20
Denali Concrete Completes Private Placement Of Shares For Above US$6 Million 22
Acquisition 22
Denali Concrete Acquires EyeFite From Can-Fite BioPharma 22
Can-Fite BioPharma Ltd - Key Competitors 24
Key Employees 25
Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27
List of Tables
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Can-Fite BioPharma Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Can-Fite BioPharma Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Can-Fite BioPharma Enters into Distribution Agreement with Chong Kun Dang Pharma 11
Can-Fite BioPharma To Enter Into Co-Development Agreement With Smart Assays BioTech 11
Cipher Pharma Enters into Licensing Agreement with Can-Fite BioPharma for CF101 12
Can-Fite BioPharma to Raise USD5 Million in Private Placement of ADSs 13
Can-Fite BioPharma to Raise USD4.8 Million in Private Placement of Shares 14
Can-Fite BioPharma Raises USD9 Million in Private Placement of American Depository Shares 15
Can-Fite BioPharma Raises USD8 Million in Private Placement of American Depositary Shares 16
Can-Fite BioPharma Completes Private Placement Of American Depositary Shares For US$5 Million 18
Can-Fite BioPharma Completes Public Offering Of Units For US$6 Million 19
OphthaliX Files Registration Statement For Public Offering Of Shares For US$10 Million 20
Can-Fite BioPharma Completes Public Offering Of Units For US$7.2 Million 20
Denali Concrete Completes Private Placement Of Shares For Above US$6 Million 22
Denali Concrete Acquires EyeFite From Can-Fite BioPharma 22
Can-Fite BioPharma Ltd, Key Competitors 24
Can-Fite BioPharma Ltd, Key Employees 25
Can-Fite BioPharma Ltd, Other Locations 26
Can-Fite BioPharma Ltd, Subsidiaries 26
List of Figures
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Can-Fite BioPharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Can-Fite BioPharma Ltd, Medical Devices Deals, 2011 to YTD 2017 9
